Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Joel Stitzel
AddedFeb 15, 2024
UpdatedMay 31, 2026
Joel Stitzel

Joel Stitzel

Board Member, Wake Forest School of Medicine

LinkedIn

Joel Stitzel's Career

Wake Forest School of Medicine
Wake Forest School of Medicine

Winston-Salem, NC, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Joel Stitzel's Career

Wake Forest School of Medicine
Wake Forest School of Medicine
Angel$18.6M10k1902Winston-Salem, NC, US
Board Member· Board

Similar to Wake Forest School of Medicine

Wake Forest Institute for Regenerative MedicineWake Forest Institute for Regenerative MedicineWinston-Salem, NC, USest. 2004Wake Forest Institute for Regenerative MedicineWinston-Salem, NC, US · est. 2004

WFIRM: A leading research institute in regenerative medicine, affiliated with Wake Forest School of Medicine.

Series B · $75M154
Harvard Medical SchoolHarvard Medical SchoolBoston, MA, USMedical Education, Researchest. 1782Harvard Medical SchoolBoston, MA, US · est. 1782

Harvard Medical School: Premier U.S. institution for medical education and immunological research in Boston, MA.

Series B · $40.6M12.5k
Washington University School of MedicineWashington University School of MedicineSt. Louis, MO, USMedical Educationest. 1891Washington University School of MedicineSt. Louis, MO, US · est. 1891

St. Louis-based Washington University School of Medicine offers diverse graduate degrees in health sciences.

Series B · $370.2M10k
NYU Grossman School of MedicineNYU Grossman School of MedicineNew York City, NY, USMedical Educationest. 1841NYU Grossman School of MedicineNew York City, NY, US · est. 1841

NYU Grossman School of Medicine: A renowned medical institution under NYU Langone Health, NYC.

Series A · $5.7M10k

Joel Stitzel's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Joel Stitzel

Kevin OttoKevin OttoBoard Member · University of FloridaZion TseZion TseBoard Member · University of YorkRobert KirschRobert KirschBoard Member · Case Western Reserve UniversityWilliam S. MarrasWilliam S. MarrasBoard Member · The Ohio State UniversityEric BreyEric BreyBoard Member · Utsa - The University of Texas at San AntonioWarren M GrillWarren M GrillBoard Member · NDI Medical